110 related articles for article (PubMed ID: 35476744)
41. CHANGING FACE OF MEDICARE'S NATIONAL COVERAGE DETERMINATIONS FOR TECHNOLOGY.
Chambers JD; Chenoweth MD; Pyo J; Cangelosi MJ; Neumann PJ
Int J Technol Assess Health Care; 2015 Jan; 31(5):347-54. PubMed ID: 26750558
[TBL] [Abstract][Full Text] [Related]
42. Effect of nonpayment for preventable infections in U.S. hospitals.
Lee GM; Kleinman K; Soumerai SB; Tse A; Cole D; Fridkin SK; Horan T; Platt R; Gay C; Kassler W; Goldmann DA; Jernigan J; Jha AK
N Engl J Med; 2012 Oct; 367(15):1428-37. PubMed ID: 23050526
[TBL] [Abstract][Full Text] [Related]
43. The quality of Medicaid and Medicare data obtained from CMS and its contractors: implications for pharmacoepidemiology.
Leonard CE; Brensinger CM; Nam YH; Bilker WB; Barosso GM; Mangaali MJ; Hennessy S
BMC Health Serv Res; 2017 Apr; 17(1):304. PubMed ID: 28446159
[TBL] [Abstract][Full Text] [Related]
44. Hospital Response to CMS Public Reports of Hospital Charge Information.
Carey K; Dor A
Med Care; 2020 Jan; 58(1):70-73. PubMed ID: 31651745
[TBL] [Abstract][Full Text] [Related]
45. A look at the Joint Commission: CMS approves continued deeming authority.
Bull Am Coll Surg; 2010 Mar; 95(3):49. PubMed ID: 21456408
[No Abstract] [Full Text] [Related]
46. Brain amyloid in normal aging and cerebral amyloid angiopathy is antigenically related to Alzheimer's disease beta-protein.
Coria F; Castaño EM; Frangione B
Am J Pathol; 1987 Dec; 129(3):422-8. PubMed ID: 3322021
[TBL] [Abstract][Full Text] [Related]
47. Hospital Characteristics Associated With Penalties in the Centers for Medicare & Medicaid Services Hospital-Acquired Condition Reduction Program.
Rajaram R; Chung JW; Kinnier CV; Barnard C; Mohanty S; Pavey ES; McHugh MC; Bilimoria KY
JAMA; 2015 Jul; 314(4):375-83. PubMed ID: 26219055
[TBL] [Abstract][Full Text] [Related]
48. Making the CMS payment policy for healthcare-associated infections work: organizational factors that matter.
Hoff T; Hartmann CW; Soerensen C; Wroe P; Dutta-Linn M; Lee G
J Healthc Manag; 2011; 56(5):319-35; discussion 335-6. PubMed ID: 21991680
[TBL] [Abstract][Full Text] [Related]
49. Effects of amyloid pathology and neurodegeneration on cognitive change in cognitively normal adults.
Bilgel M; An Y; Helphrey J; Elkins W; Gomez G; Wong DF; Davatzikos C; Ferrucci L; Resnick SM
Brain; 2018 Aug; 141(8):2475-2485. PubMed ID: 29901697
[TBL] [Abstract][Full Text] [Related]
50. Trends in Publicly Reported Quality Measures of Hospital Imaging Efficiency, 2011-2018.
Davis M; McKiernan C; Lama S; Parzynski C; Bruetman C; Venkatesh A
AJR Am J Roentgenol; 2020 Jul; 215(1):153-158. PubMed ID: 32432908
[No Abstract] [Full Text] [Related]
51. Amyloid beta peptide immunotherapy in Alzheimer disease.
Delrieu J; Ousset PJ; Voisin T; Vellas B
Rev Neurol (Paris); 2014 Dec; 170(12):739-48. PubMed ID: 25459121
[TBL] [Abstract][Full Text] [Related]
52. The National Institute on Aging and the Alzheimer's Association Research Framework for Alzheimer's disease: Perspectives from the Research Roundtable.
Knopman DS; Haeberlein SB; Carrillo MC; Hendrix JA; Kerchner G; Margolin R; Maruff P; Miller DS; Tong G; Tome MB; Murray ME; Nelson PT; Sano M; Mattsson N; Sultzer DL; Montine TJ; Jack CR; Kolb H; Petersen RC; Vemuri P; Canniere MZ; Schneider JA; Resnick SM; Romano G; van Harten AC; Wolk DA; Bain LJ; Siemers E
Alzheimers Dement; 2018 Apr; 14(4):563-575. PubMed ID: 29653607
[TBL] [Abstract][Full Text] [Related]
53. CMS Quality Measure Development.
Duseja R; Durham M; Schreiber M
JAMA; 2020 Sep; 324(12):1213-1214. PubMed ID: 32960231
[No Abstract] [Full Text] [Related]
54. Making medication therapy management a cornerstone of community-based care for people with Alzheimer's disease and other forms of dementia.
Medicare Rights Center
Care Manag J; 2007; 8(2):87-95. PubMed ID: 17595927
[No Abstract] [Full Text] [Related]
55. Joint Replacement Volume Positively Correlates With Improved Hospital Performance on Centers for Medicare and Medicaid Services Quality Metrics.
Sibley RA; Charubhumi V; Hutzler LH; Paoli AR; Bosco JA
J Arthroplasty; 2017 May; 32(5):1409-1413. PubMed ID: 28089185
[TBL] [Abstract][Full Text] [Related]
56. Cerebral amyloidosis, ageing and Alzheimer's disease; a contribution from studies on Down's syndrome.
Mann DM
Neurobiol Aging; 1989; 10(5):397-9; discussion 412-4. PubMed ID: 2530459
[TBL] [Abstract][Full Text] [Related]
57. Medicare Program; hospital inpatient prospective payment systems for acute care hospitals and the long-term care hospital prospective payment system changes and FY2011 rates; provider agreements and supplier approvals; and hospital conditions of participation for rehabilitation and respiratory care services; Medicaid program: accreditation for providers of inpatient psychiatric services. Final rules and interim final rule with comment period.
Centers for Medicare and Medicaid Services (CMS), HHS
Fed Regist; 2010 Aug; 75(157):50041-681. PubMed ID: 20712087
[TBL] [Abstract][Full Text] [Related]
58. Centers for Medicare and Medicaid Services Positive Airway Pressure Adherence Criteria May Limit Treatment to Many Medicare Beneficiaries.
Naik S; Al-Halawani M; Kreinin I; Kryger M
J Clin Sleep Med; 2019 Feb; 15(2):245-251. PubMed ID: 30736874
[TBL] [Abstract][Full Text] [Related]
59. Medicare reimbursement policy for ambulatory blood pressure monitoring: A qualitative analysis of public comments to the Centers for Medicare and Medicaid Services.
Dixon DL; Salgado TM; Luther JM; Byrd JB
J Clin Hypertens (Greenwich); 2019 Dec; 21(12):1803-1809. PubMed ID: 31642596
[TBL] [Abstract][Full Text] [Related]
60. Sidebar: CMS seeks to fix Medicaid best-price barriers in value-based contracting for high-cost therapies in Medicaid.
Caffrey M
Am J Manag Care; 2020 Aug; 26(7 Spec No.):SP218-SP219. PubMed ID: 32840974
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
